Syngene International Ltd (SYNGENE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 197397,
    "name": "Syngene Intl.",
    "stock_name": "Syngene Intl.",
    "full_name": "Syngene International Ltd",
    "name_url": "stocks-analysis/syngene-intl",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "440.40",
    "chg": -8.35,
    "chgp": "-1.86%",
    "dir": -1,
    "prev_price": "448.75",
    "mcapval": "17,777.59 Cr",
    "mcap": "Small Cap",
    "scripcode": 539268,
    "symbol": "SYNGENE",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE398R01022",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "6.68 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/syngene-intl-197397-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syngene International Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-ltd-is-rated-sell-4000854",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SyngeneInternat_mojoScore_4000854.png",
        "date": "2026-05-20 10:10:03",
        "description": "Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Syngene International Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-technical-momentum-shifts-amid-mixed-market-signals-3988433",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SyngeneInternat_technicaldot_3988433.png",
        "date": "2026-05-13 08:00:45",
        "description": "Syngene International Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day decline of 0.83%, the stock’s technical parameters suggest a nuanced outlook for investors navigating the healthcare services sector."
      },
      {
        "title": "Syngene International Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-ltd-is-rated-sell-3982890",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SyngeneInternat_mojoScore_3982890.png",
        "date": "2026-05-09 10:10:03",
        "description": "Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Syngene International Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-syngene-international-ltd-latest-results-good-or-bad-3970715",
        "imagepath": "",
        "date": "2026-04-30 19:14:25",
        "description": "Syngene International Ltd's latest financial results for Q4 FY26 present a nuanced picture of the company's performance. The Bengaluru-based contract research organization reported net sales of ₹1,036.50 crores, marking the highest quarterly revenue in its recent history, with a quarter-on-quarter growth of 13.02%. This sequential recovery indicates improved business momentum, likely driven by project ramp-ups and enhanced capacity utilization across its integrated research and manufacturing facilities. However, year-on-year revenue growth was modest at 1.82%, reflecting challenges in sustaining robust top-line expansion.\n\nOn the profitability front, net profit for the quarter reached ₹147.90 crores, which represents a significant quarter-on-quarter growth of 886.00%. Nevertheless, this figure reflects a year-on-year decline of 19.31%, raising concerns about the sustainability of profitability. The operatin..."
      },
      {
        "title": "Syngene International Ltd Locks at Upper Circuit With 16.6% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3970299",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_stocks_hitting_upper_circuit_3970299.png",
        "date": "2026-04-30 14:00:05",
        "description": "At Rs 518.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Syngene International Ltd locked at its upper circuit of 20% on 30 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Syngene International Ltd Sees Robust Trading Activity Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-sees-robust-trading-activity-amid-mixed-technical-signals-3969832",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_most_active_equities_by_value_3969832.png",
        "date": "2026-04-30 10:00:09",
        "description": "Syngene International Ltd, a prominent player in the Healthcare Services sector, witnessed a significant spike in trading value on 30 April 2026, emerging as one of the most actively traded stocks by value. Despite a strong intraday rally and outperformance against its sector, the stock remains under a cautious rating outlook, reflecting a complex interplay of market enthusiasm and fundamental concerns."
      },
      {
        "title": "Syngene International Ltd Sees Exceptional Volume Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-sees-exceptional-volume-surge-amid-mixed-technical-signals-3969820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_most_active_equities_by_volume_3969820.png",
        "date": "2026-04-30 10:00:05",
        "description": "Syngene International Ltd, a prominent player in the healthcare services sector, witnessed an extraordinary surge in trading volume on 30 Apr 2026, with over 75 lakh shares exchanging hands. This volume spike accompanied a robust price rally, as the stock outperformed its sector and broader market indices, signalling renewed investor interest despite a recent downgrade in its Mojo Grade."
      },
      {
        "title": "Syngene International Ltd Surges 10.18% to Day's High of Rs 477.55 — Outperforms Sector by 9.33 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-hits-intraday-high-with-1018-surge-on-30-april-2026-3969698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_priceRelatedfactors_3969698.png",
        "date": "2026-04-30 09:30:47",
        "description": "While the Sensex declined by 1.22% on 30 Apr 2026, Syngene International Ltd surged 10.18%, touching an intraday high of Rs 477.55. This 9.33-percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally amid a broadly weak market environment."
      },
      {
        "title": "Syngene International Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-ltd-is-rated-sell-3966322",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_mojoScore_3966322.png",
        "date": "2026-04-28 10:10:55",
        "description": "Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company's outlook."
      }
    ],
    "total": 15,
    "sid": "197397",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/syngene-international-197397"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "16-Jun-2026",
      "details": "Intimation of Schedule of Meeting with Analyst/Institutional Investor on June 19 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Jun-2026",
      "details": "Intimation of Schedule of Meeting with Analyst/Institutional Investor(s) on June 10 2026 and June 11 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "22-May-2026",
      "details": "Newspaper Advertisement - Notice of transfer of equity shares to Investor Education and Protection Fund",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has declared <strong>12%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Jun 19",
          "dt": "2019-06-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Syngene International Ltd is Rated Sell

2026-05-20 10:10:03

Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on its fundamentals, valuation, financial trends, and technical outlook.

Syngene International Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-13 08:00:45

Syngene International Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day decline of 0.83%, the stock’s technical parameters suggest a nuanced outlook for investors navigating the healthcare services sector.

Syngene International Ltd is Rated Sell

2026-05-09 10:10:03

Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Are Syngene International Ltd latest results good or bad?

2026-04-30 19:14:25

Syngene International Ltd's latest financial results for Q4 FY26 present a nuanced picture of the company's performance. The Bengaluru-based contract research organization reported net sales of ₹1,036.50 crores, marking the highest quarterly revenue in its recent history, with a quarter-on-quarter growth of 13.02%. This sequential recovery indicates improved business momentum, likely driven by project ramp-ups and enhanced capacity utilization across its integrated research and manufacturing facilities. However, year-on-year revenue growth was modest at 1.82%, reflecting challenges in sustaining robust top-line expansion. On the profitability front, net profit for the quarter reached ₹147.90 crores, which represents a significant quarter-on-quarter growth of 886.00%. Nevertheless, this figure reflects a year-on-year decline of 19.31%, raising concerns about the sustainability of profitability. The operatin...

Syngene International Ltd Locks at Upper Circuit With 16.6% Gain — Buyers Queue, Sellers Absent

2026-04-30 14:00:05

At Rs 518.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Syngene International Ltd locked at its upper circuit of 20% on 30 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Syngene International Ltd Sees Robust Trading Activity Amid Mixed Technical Signals

2026-04-30 10:00:09

Syngene International Ltd, a prominent player in the Healthcare Services sector, witnessed a significant spike in trading value on 30 April 2026, emerging as one of the most actively traded stocks by value. Despite a strong intraday rally and outperformance against its sector, the stock remains under a cautious rating outlook, reflecting a complex interplay of market enthusiasm and fundamental concerns.

Syngene International Ltd Sees Exceptional Volume Surge Amid Mixed Technical Signals

2026-04-30 10:00:05

Syngene International Ltd, a prominent player in the healthcare services sector, witnessed an extraordinary surge in trading volume on 30 Apr 2026, with over 75 lakh shares exchanging hands. This volume spike accompanied a robust price rally, as the stock outperformed its sector and broader market indices, signalling renewed investor interest despite a recent downgrade in its Mojo Grade.

Syngene International Ltd Surges 10.18% to Day's High of Rs 477.55 — Outperforms Sector by 9.33 Percentage Points

2026-04-30 09:30:47

While the Sensex declined by 1.22% on 30 Apr 2026, Syngene International Ltd surged 10.18%, touching an intraday high of Rs 477.55. This 9.33-percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally amid a broadly weak market environment.

Syngene International Ltd is Rated Sell

2026-04-28 10:10:55

Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company's outlook.

View All News